v3.26.1
SCHEDULE OF BASIC LOSS PER COMMON SHARE POTENTIAL DILUTIVE SECURITIES (Details) - USD ($)
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]    
Net loss attributable to Intelligent Bio Solutions Inc. $ (12,430,975) $ (10,568,733)
Basic net loss per share attributed to common shareholders [1] $ (8.44) $ (20.04)
Diluted net loss per share attributed to common shareholders [1] $ (8.44) $ (20.04)
Weighted-average number of shares outstanding, basic [1] 1,472,744 527,364
Weighted-average number of shares outstanding, diluted [1] 1,472,744 527,364
[1] Common stock and per share amounts have been retroactively adjusted to reflect a 1-for-10 reverse stock split effected on December 15, 2025, throughout the consolidated financial statements unless otherwise stated.